4308 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Completed
Has Results
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
Condition: Condylomata Acuminata
Intervention:
8 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
9 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
10 Not yet recruiting Maraviroc Efficacy for Hepatitis C
Conditions: Hepatitis C;   Human Immunodeficiency Virus
Intervention: Drug: Maraviroc
11 Not yet recruiting Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women
Condition: HIV Infection
Interventions: Drug: Griffithsin Gel;   Drug: Placebo Gel
12 Recruiting New Strategies to Assess Anal Cancer Risk In Women
Conditions: Human Immunodeficiency Virus (HIV);   Human Papillomavirus (HPV)
Interventions: Procedure: Perianal and Digital Anorectal Exam;   Procedure: Cervical Swabs;   Procedure: Anal Swabs;   Procedure: High Resolution Anoscopy (HRA)
13 Not yet recruiting Early ART to Limit Infection and Establishment of Reservoir
Condition: HIV-1 Infection
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
14 Not yet recruiting A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 (Prodrug) From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects
Condition: HIV (Human Immuno-Deficiency Virus)
Interventions: Drug: BMS-663068 (1 tablet at 600 mg);   Drug: BMS-663068 (4 tablets at 150 mg each tablet)
15 Recruiting Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients
Condition: HIV Infection
Intervention: Other: additional blood sample
16 Recruiting Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women
Condition: Human Immunodeficiency Virus
Intervention: Device: Dapivirine Vaginal Ring
17 Completed Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food
Conditions: Herpes Genitalis;   Herpes Zoster
Interventions: Drug: ASP2151;   Drug: Placebo
18 Not yet recruiting Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Condition: HIV Infections
Interventions: Biological: MVA/HIV62B vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo
19 Recruiting Autonomic Neuropathy, GI Motility, and Inflammation in HIV
Condition: HIV Disease
Intervention: Drug: Pyridostigmine
20 Not yet recruiting Romidepsin Plus 3BNC117 Phase 2a Study
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: 3BNC117;   Drug: Romidepsin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years